- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- 3 states take steps to restrict kratom
- Ochsner CEO: How listening changed the way I lead
- Leading through disruption: 6 ways healthcare CEOs turn trends into strategic advantage
- What’s keeping 11 behavioral health leaders up at night
- Providence to completely exit insurance business after Medicare Advantage deal falls through
- What a children’s hospital learned from the Blue Angels
- CorroHealth executive joins 2026 PRNEWS People of the Year class
- How Allina Health’s AI operating system drove $7.3M in added annual surgical contribution margin
- Total enrollment for 73 dental schools in the U.S.
- 55 hospital and health system CISOs and chief privacy officers to know | 2026
- What’s driving Providence’s $400M turnaround
- The dental specialty seeing the largest drop in education enrollment
- Women’s hospital, health system leadership representation ticks up in 2026
- 4 recent hospital, health system CFO exits
- Dental school enrollment up 10% since 2021
- Heartland Dental ranks among best-in-state employers: Forbes
- Virginia dental practice opens 5th location
- The 5 highest-paid cardiologists in Kansas City
- 8 federal government, policy updates for dental leaders to know
- Florida oral surgery practice damaged in fire
- 6 DSOs making headlines
- How AI is reshaping behavioral healthcare
- DermCare Management, US Dermatology Partners form national dermatology group
- 29 new behavioral health study findings to know
- The real reason ASC anesthesia departments struggle — and it’s not operations
- Nevada cuts psychiatric residential placements for children from 35% to 16%
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Seattle Children’s expands with $103M ASC
- 5 cardiologists in the headlines
- The toughest talks ASC leaders have with physicians
- Alabama developers to break ground on $35M ASC
- The specialties driving ASC growth through 2031
- Is the behavioral health access problem actually a quality problem?
- Nurses at SSM Health outpatient practices move to unionize
- 62% of ASCs cancel, delay cases over anesthesia gaps
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Patient advocacy group sues AMA for open access to CPT system
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- Luigi Mangione pleads guilty in federal case over murder of UnitedHealthcare CEO Brian Thompson
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Insurers denied between 12% to 18% of prior authorization requests in 2025: KFF
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Massachusetts moves to restrict kratom sales
- Meet the leaders of the fastest-growing dental practices
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Mental healthcare provider gaps, by state
- Hippocratic AI rolls out platform to coordinate teams of conversational voice AI agents
- 23 new behavioral health projects to know
- Major PBMs agree to offer TrumpRx pricing information to members
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers providers, PBMs to DOJ over youth gender care billing
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Weekly Rundown: US News rates GLP-1 telehealth platforms; CHAI launches AI cybersecurity work group
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
Obviously, these "behavioral science" results aren't to be trusted. The really tricky policy question is identifying the special interest behind it. Who benefits from skewing this data?
And the real-world conundrum: how much "behavioral health science" is also on shaky ground?
Francesca Gino, a prominent Harvard Business School professor, alleged to have falsified results in behavioral science studiesOver the last few weeks, allegations have surfaced against Francesca Gino, a prominent Harvard Business School (HBS) professor who has been accused of falsifying results in several behavioral science studies.
On 16 June, the Chronicle of Higher Education reported that Max Bazerman, a HBS professor and co-author who published a paper in 2012 alongside Gino, said that Harvard informed him that it believed one of the studies overseen by Gino had falsified results.
The paper in question is on findings published in – and later retracted by – the Proceedings of the National Academy of Sciences and surrounds an experiment that asked participants to fill out tax and insurance paperwork.
“Many written forms required by businesses and governments rely on honest reporting. Proof of honest intent is typically provided through signature at the end of, eg, tax returns or insurance policy forms. Still, people sometimes cheat to advance their financial self-interests at great costs to society. We test an easy-to-implement method to discourage dishonesty: signing at the beginning rather than at the end of a self-report, thereby reversing the order of the current practice,” the paper’s abstract read.
The study claimed to have discovered that participants who were asked to sign truthfulness declarations at the top of the page were more honest than those who were asked to sign the declarations at the bottom of the page.
According to the Chronicle of Higher Education, Bazerman said that the university provided a 14-page document that included “compelling evidence” of data falsification, including the discovery that someone accessed a database and added and altered data in the file. He went on to deny any involvement in the alleged data tampering, telling the Chronicle: “I did not have anything to do with the fabrication.”
A day later, a blog called DataColada and run by three behavioral science academics published a four-part series of posts that detailed extensive evidence of the alleged fraud in four academic papers co-authored by Gino.
“We discovered evidence of fraud in papers spanning over a decade, including papers published quite recently (in 2020),” the blog authors, ESADE Business School’s Uri Simonsohn, University of California, Berkeley’s Leif Nelson, and University of Pennsylvania’s Joseph Simmons, wrote.
“In the fall of 2021, we shared our concerns with Harvard Business School. Specifically, we wrote a report about four studies for which we had accumulated the strongest evidence of fraud. We believe that many more Gino-authored papers contain fake data. Perhaps dozens,” the scholars said.
“We understand that Harvard had access to much more information than we did, including, where applicable, the original data collected using Qualtrics survey software. If the fraud was carried out by collecting real data on Qualtrics and then altering the downloaded data files, as is likely to be the case for three of these papers, then the original Qualtrics files would provide airtight evidence of fraud. (Conversely, if our concerns were misguided, then those files would provide airtight evidence that they were misguided),” they added.
To the best of their knowledge, none of Gino’s co-authors carried out or assisted with the data collection for the studies in question, the scholars said.
According to Gino’s HBS profile, she is currently on administrative leave.
Speaking to the New York Times, a man who identified himself as Gino’s husband said: “It’s obviously something that is very sensitive that we can’t speak to now.”
Faulty tools, faulty results.
Today Morning Brew delivers a concise description of the Excel flaw that skewed gene studies.
Microsoft updates Excel feature that caused problems for scientists
The feature, known as Automatic Data Conversion, converted certain human gene names into dates and created massive errors in scientific research.
Microsoft is finally tweaking an Excel feature that has caused nearly two decades of grief for scientists. The feature, known as Automatic Data Conversion, which in the past constantly converted certain human gene names into dates and created massive errors in scientific research, can now be disabled.
If your science background is more Intro to Geology…every one of the nearly 44,000 human genes has a shortened version of its name and a symbol. So when a scientist typed SEPT1 to represent the Septin-1 gene in an Excel sheet, the program would assume they meant September 1 and change it. And if you’ve ever been the dogsbody who has to comb through an Excel file, you know it’s easy to miss a tiny error like this.
But those tiny errors amounted to big problems: A study of 10,000 scientific papers on genes published from 2014–2020 found that more than 30% contained a gene name error that was Excel's fault. It got so bad that by 2020 the governing body behind gene naming had updated 27 gene names so they couldn’t be mistaken in the Microsoft program (i.e. SEPT1 became SEPTIN1).
How to turn it off: You can now personalize Excel’s auto correcting functions under File>Options>Data.
https://www.morningbrew.com/daily/stories/updates-excel-caused-problems-scientists30% in 17 years.
3,000 papers in genes. That's a lot of research, and it touches a lot of lives.
Wonder how many drugs were impacted?
Is this part of the reason for the pre/post-release discrepancies in so many drugs?
Is the current rush to capture all Sickle Cell carriers founded on any of these errors?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























